Legal Issues and BPCI Act


The legal issues pertaining to the follow-on-Biologics and Biosimilars are one of the most aspects that require an open discussion. Before the actual advent of Biosimilars to the market legal issues have risen in numbers in their developmental stages. Renowned organizations have filed cases against each other two claim their rights and for other legal allegations related to the products. This track is dedicated to discussion of all such cases which has been argued in the court of law. By 2002, the FDA had approved 36 new Biologics, followed by 37 more in 2003, another 40 in 2004 and 39 more in 2005. By 2006, the leading category of biologic treatment, the red blood cell enhancer recombinant erythropoietin (EPO), generated $14 billion in sales revenues, or 40 percent more than the best-selling traditional pharmaceutical, Lipitor. More than 300 therapeutic antibodies currently are in clinical development and trials, compared to just 13 that already are widely available due to legal issues


    Related Conference of Legal Issues and BPCI Act

    May 12-12, 2021

    27th Cognitive Neuroscience Congress

    London, UK
    May 17-17, 2021

    Annual Meet on Pharmacovigilance & Drug Safety

    Tokyo, Japan
    May 17-18, 2021

    8th European Biopharma Congress

    Prague, Czech Republic
    June 07-08, 2021

    2nd European Conference on Pharmacovigilance and Drug Safety

    Prague, Czech Republic
    June 21-22, 2021

    1 st Global Summit on Generic Drugs and Quality Control

    Prague, Czech Republic
    July 06-07, 2021

    14th Global Pharmacovigilance And Clinical Trials Summit

    Albufeira, Portugal
    July 10-11, 2021

    2 nd Pharma Expo China

    Tokyo, Japan
    July 13-14, 2021

    24th Asia Pacific Pharma Congress

    Melbourne,
    July 26-27, 2021

    36th World Pharmacology and Therapeutics Forum

    Paris, France
    July 30-30, 2021

    12th World Congress on Bioavailability and Bioequivalence

    Prague, Czech Republic
    August 16-17, 2021

    Global summit on Cosmetic & Reconstructive Surgery

    Tokyo, Japan
    August 16-17, 2021

    34rd World Congress on Pharmacology

    London, UK
    August 23-24, 2021

    7th World Congress on Medicinal Plants and Marine Drugs

    Prague, Czech Republic
    August 30-31, 2021

    20th Medicinal & PharmaceuticalSciences Congress

    London, UK
    September 13-14, 2021

    3rd World Congress on Drug Discovery and Drug Design

    Tokyo, Japan
    September 17-18, 2021

    9th International Conference on Clinical Trials

    Montreal, Canada
    September 20-21, 2021

    Asia Pacific Pharmaceutics & Drug Delivery Congress

    Tokyo, Japan
    September 27-28, 2021

    2 nd World Pharma Expo

    Tokyo, Japan
    October 05-06, 2021

    International Congress on Drug Delivery

    Auckland, Newzealand
    October 21-22, 2021

    2nd Annual Congress on Antibiotics and Bacterial Infections

    Geneva, Switzerland
    October 29-30, 2021

    14th World Drug Delivery Summit

    Vancouver, Canada
    October 29-30, 2021

    12th Annual Biomarkers and Clinical Research Congress

    Vancouver, Canada
    November 16-17, 2021

    World Congress on Biologics and Biosimilars

    Osaka, Japan
    November 26-27, 2021

    World Biosimilars & Biologics Congress

    Vancouver, Canada
    December 02-03, 2021

    17th Annual Congress on Pharmacology and Toxicology

    Tokyo, Japan
    December 02-03, 2021

    International Conference on Bio Pharmaceutics

    Auckland, Newzealand
    December 07-08, 2021

    2nd International Conference on Biotechnology and Healthcare

    Auckland, Newzealand
    December 15-16, 2021

    12th World Congress on Bioavailability and Bioequivalence

    Bali, Indonesia

    Legal Issues and BPCI Act Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in